Fifth Third Bancorp’s Maravai LifeSciences MRVI Stock Holding History

Fifth Third Bancorp’s Portfolio MRVI Stock Details MRVI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$6.42K	Buy	1,029 +145	+16%	+$626	﹤0.01%	3861
2026 Q1	$2.5K	Buy	+884	New	+$3K	﹤0.01%	3997
2023 Q3	–	Sell	-16,560	Closed	-$206K	–	2650
2023 Q2	$206K	Sell	16,560 -921	-5%	-$12.4K	﹤0.01%	959
2023 Q1	$245K	Buy	17,481 +17,396	+20,466%	+$250K	﹤0.01%	952
2022 Q4	$1.22K	Buy	+85	New	+$1.34K	﹤0.01%	2507

Other funds holding MRVI

GTCR LLC Chicago, Illinois $3.91B AUM 14.64% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

1WCM

12 West Capital Management New York $535M AUM 25.99% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

OAM

Ophir Asset Management Sydney, Australia $1.22B AUM 100.03% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return

Fifth Third Bancorp's MRVI Position: Q2 2026 in Review

Fifth Third Bancorp increased its Maravai LifeSciences (MRVI) stake by 16% in Q2 2026, buying an estimated $626 and bringing the position to 1,029 shares worth $6.42K. The position accounts for ﹤0.01% of the portfolio, ranked #3861.

Fifth Third Bancorp first reported a position in MRVI in Q4 2022 and has held it in 5 quarters since. The position peaked at $245K in Q1 2023. 178 funds tracked by Wall St. Rank hold MRVI as of Q2 2026.

Fifth Third Bancorp held 1,029 shares of Maravai LifeSciences worth $6.42K as of Q2 2026.
Fifth Third Bancorp bought 145 Maravai LifeSciences shares in Q2 2026, an estimated $626.
Maravai LifeSciences made up ﹤0.01% of Fifth Third Bancorp's portfolio in Q2 2026, its #3861 holding.
Fifth Third Bancorp first reported a position in Maravai LifeSciences in Q4 2022 and has held it in 5 quarters since.
Fifth Third Bancorp's Maravai LifeSciences position peaked at $245K in Q1 2023.
178 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q2 2026.

Based on Fifth Third Bancorp's 13F filing for Q2 2026, filed 5 Aug 2026.